Published in Diabetes on July 07, 2016
Nicotine Induces Podocyte Apoptosis through Increasing Oxidative Stress. PLoS One (2016) 0.75
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA (2004) 6.74
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci (2010) 5.27
Permeation and block of N-methyl-D-aspartic acid receptor channels by divalent cations in mouse cultured central neurones. J Physiol (1987) 5.22
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci (2013) 4.35
Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes (2009) 3.16
Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch (2010) 2.83
A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease. Arch Neurol (2006) 2.62
Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment. Nat Med (2015) 2.27
The chemical biology of clinically tolerated NMDA receptor antagonists. J Neurochem (2006) 2.13
The proximal tubule in the pathophysiology of the diabetic kidney. Am J Physiol Regul Integr Comp Physiol (2011) 1.84
Calcium permeability of the N-methyl-D-aspartate receptor channel in hippocampal neurons in culture. Proc Natl Acad Sci U S A (1993) 1.63
Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial. Am J Geriatr Psychiatry (2006) 1.57
Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study. Kidney Int (1998) 1.56
Functional NMDA receptors with atypical properties are expressed in podocytes. Am J Physiol Cell Physiol (2010) 1.54
N-methyl-D-aspartate receptor subunit NR3a expression and function in principal cells of the collecting duct. Am J Physiol Renal Physiol (2011) 1.48
Mechanisms and treatment of CKD. J Am Soc Nephrol (2012) 1.46
US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2016) 1.37
Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice. Am J Physiol Renal Physiol (2009) 1.36
Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism. Ann N Y Acad Sci (2010) 1.31
Glomerular podocytes contain neuron-like functional synaptic vesicles. FASEB J (2006) 1.27
A PAI-1 mutant, PAI-1R, slows progression of diabetic nephropathy. J Am Soc Nephrol (2008) 1.24
Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders. J Alzheimers Dis (2004) 1.20
Protection of podocytes from hyperhomocysteinemia-induced injury by deletion of the gp91phox gene. Free Radic Biol Med (2010) 1.12
Nephrin binds to the COOH terminus of a large-conductance Ca2+-activated K+ channel isoform and regulates its expression on the cell surface. Am J Physiol Renal Physiol (2008) 1.11
NMDA receptor-dependent long-term potentiation comprises a family of temporally overlapping forms of synaptic plasticity that are induced by different patterns of stimulation. Philos Trans R Soc Lond B Biol Sci (2013) 1.05
Insulin increases surface expression of TRPC6 channels in podocytes: role of NADPH oxidases and reactive oxygen species. Am J Physiol Renal Physiol (2011) 1.04
Mesangial cells derived from rat glomeruli produce an erythropoiesis stimulating factor in cell culture. FEBS Lett (1982) 0.99
MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients. Diabetes Res Clin Pract (2006) 0.97
Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn study. Arterioscler Thromb Vasc Biol (2001) 0.96
Renal NMDA receptors independently stimulate proximal reabsorption and glomerular filtration. Am J Physiol Renal Physiol (2009) 0.94
The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation. Obesity (Silver Spring) (2015) 0.93
Regulation of podocyte BK(Ca) channels by synaptopodin, Rho, and actin microfilaments. Am J Physiol Renal Physiol (2010) 0.93
The podocyte power-plant disaster and its contribution to glomerulopathy. Front Endocrinol (Lausanne) (2014) 0.93
Opposing effects of podocin on the gating of podocyte TRPC6 channels evoked by membrane stretch or diacylglycerol. Am J Physiol Cell Physiol (2013) 0.92
Methyltetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia as a novel risk factor for diabetic nephropathy. Endocrine (2009) 0.92
Filtration in single isolated mammalian glomeruli. Kidney Int (1981) 0.91
Hydrogen sulfide deficiency and diabetic renal remodeling: role of matrix metalloproteinase-9. Am J Physiol Endocrinol Metab (2013) 0.90
NMDA receptor-mediated activation of NADPH oxidase and glomerulosclerosis in hyperhomocysteinemic rats. Antioxid Redox Signal (2010) 0.89
Attenuation of beta2-adrenergic receptors and homocysteine metabolic enzymes cause diabetic cardiomyopathy. Biochem Biophys Res Commun (2010) 0.89
Glomerular and tubular function in the diabetic kidney. Adv Chronic Kidney Dis (2014) 0.85
Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy. Am J Physiol Renal Physiol (2015) 0.83
Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions. Eur J Med Chem (2003) 0.83
Elevated serum homocysteine is a predictor of accelerated decline in renal function and chronic kidney disease: A historical prospective study. Eur J Intern Med (2014) 0.83
Memantine ER, a once-daily formulation for the treatment of Alzheimer's disease. Expert Opin Pharmacother (2010) 0.79
Glutamate receptors in the kidney. Nephrol Dial Transplant (2015) 0.79
Syndecan-4 ectodomain evokes mobilization of podocyte TRPC6 channels and their associated pathways: An essential role for integrin signaling. Biochim Biophys Acta (2015) 0.78
Homocysteine as a risk factor for development of microalbuminuria in type 2 diabetes. Korean Diabetes J (2010) 0.78
N-methyl-D-aspartate receptor activation by guanidinosuccinate but not by methylguanidine: behavioural and electrophysiological evidence. Neuropharmacology (1996) 0.77
Association of homocysteine with type 1 diabetes mellitus: a meta-analysis. Int J Clin Exp Med (2015) 0.76